Skip to search.
 STI Down0.51%

Cardiome Pharma Corp. (CRME)

-NasdaqCM

2.06 19 Jun 03:59 SGT

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2012Dec 31, 2011Dec 31, 2010
Total Revenue 789   1,505   66,064  
Cost of Revenue -   -   -  
Gross Profit 789   1,505   66,064  
Operating Expenses
Research Development6,017  15,224  15,339  
Selling General and Administrative9,611  11,549  12,875  
Non Recurring10,040  95  25  
Others1,229  1,095  1,154  
Total Operating Expenses26,897  27,963  29,393  
Operating Income or Loss (25,960) (26,458) 36,671  
Income from Continuing Operations
Total Other Income/Expenses Net12,061  756  803  
Earnings Before Interest And Taxes(14,047)(25,702)37,474  
Interest Expense4,268  2,218  1,975  
Income Before Tax(18,315)(27,920)35,499  
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(7,097)(27,920)35,499  
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (18,315) (27,920) 35,499  
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (18,315) (27,920) 35,499  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.